Hcw Biologics earnings were -$22.1M for the trailing 12 months ending Jun 30, 2026, with N/A growth year over year. The latest HCWB earnings report on Jun 30, 2026 announced Q2 2026 earnings of -$15.4M, down 1,324.3% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, HCWB reported annual earnings of -$22.3M, with -25.7% growth.
On HCWB's earnings call on Aug 17, 2026, Hcw Biologics (NASDAQ: HCWB) reported Q2 2026 earnings per share (EPS) of -$11.58, up 71.56% year over year. Total HCWB earnings for the quarter were -$15.37 million. In the same quarter last year, Hcw Biologics's earnings per share (EPS) was -$40.72.
As of the last Hcw Biologics earnings report, Hcw Biologics is currently losing money. Hcw Biologics's net profit (also called net income) for the twelve months ending Jun 30, 2026 was -$5.58 million, a 51.04% decrease year over year.
What was HCWB's earnings growth in the past year?
As of Hcw Biologics's earnings date in Aug 17, 2026, Hcw Biologics's earnings has grown year over year. HCWB earnings in the past year totalled -$22.14 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.